Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

FLSCFrazier Life Sciences Acquisition Corp. II

Nasdaq · CIK 0002153598
Filer categoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Entity typeoperating
SIC6770 Blank Checks
FY end1231
XBRL facts48

Identity from submissions API

NameFrazier Life Sciences Acquisition Corp. II
CIK0002153598
TickersFLSC
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SIC6770 Blank Checks
EIN981964369
LEI—
Fiscal year end1231
State of incorporationE9 Cayman Islands
Phone650-325-5156
Website—
Investor website—
Owner org01 Energy & Transportation
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
1001 PAGE MILL ROAD
BUILDING 4, SUITE B
PALO ALTO
CA
93404
CA
Mailing address
1001 PAGE MILL ROAD
BUILDING 4, SUITE B
PALO ALTO
CA
93404
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

23 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-17 10-Q 10-Q 0001193125-26-465479 001-43504 261565958 34 2633109 1 1
2026-10-27 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001738048-26-000075 005-95969 261491282 34 35043
2026-10-22 8-K 8-K 8.01,9.01 0001193125-26-429129 001-43504 261479514 34 255145 1 1
2026-10-22 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001346824-26-000245 005-95969 261478952 34 18993
2026-10-21 SCHEDULE 13D xslSCHEDULE_13D_X02/primary_doc.xml 0001193125-26-428005 005-95969 261476815 34 135271
2026-10-21 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000921895-26-002836 005-95969 261476783 34 38555
2026-10-21 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-004630 005-95969 261475859 34 13092
2026-10-16 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-116496 005-95969 261464741 34 27267
2026-10-15 4 4 0001193125-26-422957 12577
2026-10-15 8-K 8-K 1.01,3.02,5.03,8.01,9.01 0001193125-26-422919 001-43504 261463335 34 1246533 1 1
2026-10-14 424B4 424B4 0001193125-26-421735 333-299101 261460281 33 1429576
2026-10-13 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-003227 333-299101 261458196 33 1809
2026-10-13 3 3 0001193125-26-420812 20649
2026-10-13 3 3 0001193125-26-420801 20920
2026-10-13 3 3 0001193125-26-420796 23487
2026-10-13 3 3 0001193125-26-420791 20321
2026-10-13 3 3 0001193125-26-420790 29077
2026-10-13 3 3 0001193125-26-420789 19582
2026-10-13 3 3 0001193125-26-420782 20520
2026-10-13 CERT 8A_Cert_FLSC_2153598.pdf 0001354457-26-000983 001-43504 261456645 34 181682
2026-10-08 8-A12B 8-A12B 0001193125-26-417909 001-43504 261449944 34 14703
2026-09-24 S-1 S-1 0001193125-26-399703 333-299101 261401826 33 5084563 1 1
2026-09-11 DRS filename1.htm 0001193125-26-389015 377-09749 261373666 33 2503242

Latest XBRL company facts

One latest value per concept from companyfacts (48 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
ffd NetFeeAmt NetFeeAmt USD 10,357.5 2026-09-23 S-1 2026-09-24 0001193125-26-399703
ffd TtlFeeAmt TtlFeeAmt USD 10,357.5 2026-09-23 S-1 2026-09-24 0001193125-26-399703
ffd TtlOfferingAmt TtlOfferingAmt USD 75.00M 2026-09-23 S-1 2026-09-24 0001193125-26-399703
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-09-23 S-1 2026-09-24 0001193125-26-399703
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-09-23 S-1 2026-09-24 0001193125-26-399703
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 53,183 2026-09-30 2026 Q3 10-Q 2026-11-17 0001193125-26-465479
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 71,478 2026-09-30 2026 Q3 10-Q 2026-11-17 0001193125-26-465479
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 24,812 2026-09-30 2026 Q3 10-Q 2026-11-17 0001193125-26-465479
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 4.11M 2026-10-13 2026 Q3 10-Q 2026-11-17 0001193125-26-465479
us-gaap Assets Assets USD 437,092 2026-09-30 2026 Q3 10-Q 2026-11-17 0001193125-26-465479
us-gaap AssetsCurrent Assets, Current USD 162,393 2026-09-30 2026 Q3 10-Q 2026-11-17 0001193125-26-465479
us-gaap AssetsHeldInTrust Assets Held-in-trust USD 0 2026-09-30 2026 Q3 10-Q 2026-11-17 0001193125-26-465479
us-gaap Cash Cash USD 162,393 2026-09-30 2026 Q3 10-Q 2026-11-17 0001193125-26-465479
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 162,393 2026-09-30 2026 Q3 10-Q 2026-11-17 0001193125-26-465479
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 162,393 2026-08-07 2026-09-30 2026 Q3 10-Q 2026-11-17 0001193125-26-465479
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 0 2026-09-30 2026 Q3 10-Q 2026-11-17 0001193125-26-465479
us-gaap CashFDICInsuredAmount Cash, FDIC Insured Amount USD 250,000 2026-09-30 2026 Q3 10-Q 2026-11-17 0001193125-26-465479
us-gaap DeferredCompensationLiabilityClassifiedNoncurrent Deferred Compensation Liability, Classified, Noncurrent USD 3.00M 2026-10-13 2026 Q3 10-Q 2026-11-17 0001193125-26-465479
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.07 2026-08-07 2026-09-30 2026 Q3 10-Q 2026-11-17 0001193125-26-465479
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.07 2026-08-07 2026-09-30 2026 Q3 10-Q 2026-11-17 0001193125-26-465479
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD 87,570 2026-08-07 2026-09-30 2026 Q3 10-Q 2026-11-17 0001193125-26-465479
us-gaap LiabilitiesCurrent Liabilities, Current USD 524,661 2026-09-30 2026 Q3 10-Q 2026-11-17 0001193125-26-465479
us-gaap LiquidationBasisOfAccountingAccruedCostsToDisposeOfAssetsAndLiabilities Liquidation Basis of Accounting, Accrued Costs to Dispose of Assets and Liabilities USD 100,000 2026-09-30 2026 Q3 10-Q 2026-11-17 0001193125-26-465479
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 187,392 2026-08-07 2026-09-30 2026 Q3 10-Q 2026-11-17 0001193125-26-465479
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -24,999 2026-08-07 2026-09-30 2026 Q3 10-Q 2026-11-17 0001193125-26-465479
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -112,569 2026-08-07 2026-09-30 2026 Q3 10-Q 2026-11-17 0001193125-26-465479
us-gaap NoninterestExpenseOfferingCost Noninterest Expense Offering Cost USD 750,000 2026-10-13 2026 Q3 10-Q 2026-11-17 0001193125-26-465479
us-gaap NotesPayableCurrent Notes Payable, Current USD 200,000 2026-09-30 2026 Q3 10-Q 2026-11-17 0001193125-26-465479
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-08-07 2026-09-30 2026 Q3 10-Q 2026-11-17 0001193125-26-465479
us-gaap OtherUnderwritingExpense Other Underwriting Expense USD 1.50M 2026-08-07 2026-09-30 2026 Q3 10-Q 2026-11-17 0001193125-26-465479
us-gaap PaymentsToAcquireRestrictedInvestments Payments to Acquire Restricted Investments USD 75.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001193125-26-465479
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-17 0001193125-26-465479
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 1.00M 2026-09-30 2026 Q3 10-Q 2026-11-17 0001193125-26-465479
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-17 0001193125-26-465479
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-17 0001193125-26-465479
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-17 0001193125-26-465479
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 75.00M 2026-10-13 2026 Q3 10-Q 2026-11-17 0001193125-26-465479
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 25,000 2026-08-07 2026-09-30 2026 Q3 10-Q 2026-11-17 0001193125-26-465479
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 200,000 2026-08-07 2026-09-30 2026 Q3 10-Q 2026-11-17 0001193125-26-465479
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -112,569 2026-09-30 2026 Q3 10-Q 2026-11-17 0001193125-26-465479
us-gaap SaleOfStockPricePerShare Sale of Stock, Price Per Share USD/shares 10 2026-10-13 2026 Q3 10-Q 2026-11-17 0001193125-26-465479
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 112,569 2026-08-07 2026-09-30 2026 Q3 10-Q 2026-11-17 0001193125-26-465479
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD -87,569 2026-09-30 2026 Q3 10-Q 2026-11-17 0001193125-26-465479
us-gaap StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD 437,092 2026-09-30 2026 Q3 10-Q 2026-11-17 0001193125-26-465479
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 25,000 2026-08-07 2026-09-30 2026 Q3 10-Q 2026-11-17 0001193125-26-465479
us-gaap TemporaryEquityRedemptionPricePerShare Temporary Equity, Redemption Price Per Share USD/shares 10 2026-09-30 2026 Q3 10-Q 2026-11-17 0001193125-26-465479
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 1.70M 2026-08-07 2026-09-30 2026 Q3 10-Q 2026-11-17 0001193125-26-465479
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 1.70M 2026-08-07 2026-09-30 2026 Q3 10-Q 2026-11-17 0001193125-26-465479

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →